All In Biotech

Drug Trial Radar · NCT06667453

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of PGN-EDODM1 in Adult Participants With Myotonic Dystrophy Type 1 (FREEDOM2-DM1)

Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Dec 10, 2024

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
PepGen IncIndustry
Sponsor type
Industry
First posted
Oct 31, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PGN-EDODM1 are for people with myotonic dystrophy type 1 (DM1) compared to placebo.

Conditions

  • Myotonic Dystrophy 1

Interventions

  • PGN-EDODM1Drug

    Administered by intravenous (IV) infusion

  • PlaceboOther

    Administered by intravenous (IV) infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability as assessed by number of participants with Adverse Events (AEs)Time frame: Baseline through Day 112

Locations

12 sites in 4 countries. Site status is shown where the registry gives one.

  • University of Calgary

    Calgary, Alberta, Canada · Recruiting

  • Ottawa Hospital Research Institute (OHRI)

    Ottawa, Ontario, Canada · Recruiting

  • CIUSSS du Saguenay-Lac-Saint-Jean

    Chicoutimi, Quebec, Canada · Recruiting

  • Montreal Neurological Institute

    Montreal, Quebec, Canada · Recruiting

  • Pacific Clinical Research Network Auckland

    Takapuna, Auckland, New Zealand · Recruiting

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea · Recruiting

  • Seoul National University Hospital

    Seoul, South Korea · Recruiting

  • Pusan National University Yangsan Hospital

    Pusan, Gyeongsangnam-do, South Korea · Recruiting

  • Cardiff and Vale Hospital

    Cardiff, United Kingdom · Recruiting

  • Newcastle Upon Tyne Hospitals

    Newcastle upon Tyne, United Kingdom · Recruiting

  • Salford Royal Hospital

    Salford, England, United Kingdom · Recruiting

  • University College London Hospitals NHS Foundation Trust

    London, UK, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.